4.5 Article

You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment

Shana D. Stites et al.

Summary: The stigma of dementia spills over into preclinical AD, and the availability of treatment does not alter that stigma.

SOCIAL SCIENCE & MEDICINE (2022)

Article Geriatrics & Gerontology

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer's Disease Biomarkers and Mood Symptoms

Catherine E. Munro et al.

Summary: This study investigates the longitudinal trajectories of cognitive concerns reported by participants and their study partners, and explores the relationship between these concerns, AD biomarkers, and mood symptomatology. The results suggest that baseline mood significantly influences participant-rated concerns, while baseline amyloid and tau levels have a significant impact on study partner concerns. These findings highlight the importance of remote assessments of study partner-reported concerns in understanding the AD clinical spectrum.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Clinical Neurology

Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials

Olivia M. Bernstein et al.

Summary: Early study exit in Alzheimer's disease clinical trials can reduce statistical power and increase bias risk. The type of study partner may influence the completion rate of the trial.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Medicine, General & Internal

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

Rema Raman et al.

Summary: Racial/ethnic groups showed differences in recruitment sources, reasons for screen failure, and overall probability of eligibility in a preclinical AD trial. These results emphasize the necessity for improved recruitment strategies and careful consideration of eligibility criteria in planning preclinical AD clinical trials.

JAMA NETWORK OPEN (2021)

Editorial Material Medicine, General & Internal

Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound

Jennifer J. Manly et al.

JAMA NETWORK OPEN (2021)

Article Ethics

'That would be dreadful': The ethical, legal, and social challenges of sharing your Alzheimer's disease biomarker and genetic testing results with others

Emily A. Largent et al.

Summary: Ongoing large clinical trials are aiming to discover therapies to delay or prevent dementia caused by Alzheimer's disease, raising the possibility of widespread adoption of biomarker and genetic testing for cognitively unimpaired individuals in the future. However, concerns such as stigma and discrimination when sharing these test results highlight the need for additional legal protections and policy changes.

JOURNAL OF LAW AND THE BIOSCIENCES (2021)

Editorial Material Clinical Neurology

Addressing Health Disparities Among Minority Populations Why Clinical Trial Recruitment Is Not Enough

Consuelo H. Wilkins et al.

JAMA NEUROLOGY (2020)

Article Geriatrics & Gerontology

A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners

Chelsea G. Cox et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)

Article Clinical Neurology

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials

Michelle M. Nuno et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

Article Clinical Neurology

Study partner-reported decline identifies cognitive decline and dementia risk

Rachel L. Nosheny et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Medicine, General & Internal

A Framework for Ethical Payment to Research Participants

Luke Gelinas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Editorial Material Oncology

Addressing Financial Barriers to Enrollment in Clinical Trials

Emily A. Largent et al.

JAMA ONCOLOGY (2018)

Editorial Material Clinical Neurology

Study partners: essential collaborators in discovering treatments for Alzheimer's disease

Emily A. Largent et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Article Gerontology

Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role

Betty S. Black et al.

DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE (2018)

Review Psychology, Clinical

Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta-Analysis

Timothy W. Brearly et al.

NEUROPSYCHOLOGY REVIEW (2017)

Review Clinical Neurology

Study partners should be required in preclinical Alzheimer's disease trials

Joshua D. Grill et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Review Clinical Neurology

Dementia registries around the globe and their applications: A systematic review

Karolina Krysinska et al.

ALZHEIMERS & DEMENTIA (2017)

Editorial Material Clinical Neurology

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

Keith N. Fargo et al.

ALZHEIMERS & DEMENTIA (2016)

Article Clinical Neurology

Why are Spousal Caregivers More Prevalent than Nonspousal Caregivers as Study Partners in AD Dementia Clinical Trials?

Mark S. Cary et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2015)

Article Family Studies

The Growing Racial and Ethnic Divide in US Marriage Patterns

R. Kelly Raley et al.

FUTURE OF CHILDREN (2015)

Article Health Care Sciences & Services

Obstacles And Opportunities In Alzheimer's Clinical Trial Recruitment

Jennifer L. Watson et al.

HEALTH AFFAIRS (2014)

Article Psychology, Clinical

Researchers' perspectives on the role of study partners in dementia research

Betty S. Black et al.

INTERNATIONAL PSYCHOGERIATRICS (2014)

Article Clinical Neurology

Effect of study partner on the conduct of Alzheimer disease clinical trials

Joshua D. Grill et al.

NEUROLOGY (2013)

Review Clinical Neurology

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials

Joshua D. Grill et al.

ALZHEIMERS RESEARCH & THERAPY (2010)

Article Public, Environmental & Occupational Health

Three approaches to qualitative content analysis

HF Hsieh et al.

QUALITATIVE HEALTH RESEARCH (2005)